2nd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$193,614
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

US House of Representatives, US Senate, EOP, HHS, CMS

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); SENATE; Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC)

Health Issues HCR

US House of Representatives, HHS, HRSA, White House Office, CDC, CMS, FDA, GAO, OMB, EOP

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; White House Office; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

US House of Representatives, US Senate, HHS, HRSA

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); White House Office; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Office of Management & Budget (OMB); SENATE; Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Medicare/Medicaid MMM

US House of Representatives, US Senate, CMS, EOP, HHS, MedPAC, White House Office

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); White House Office; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC)

Taxation/Internal Revenue Code TAX

US HOuse of Representatives, US Senate

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO)

Education EDU

US House of Representatives, US Senate

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); White House Office; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); SENATE

Medical/Disease Research/Clinical Labs MED

US House of Representatives, US Senate, HHS, HRSA, AHRQ

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); White House Office; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Torts TOR

US House of Representatives, US Senate

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: White House Office; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.